This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Dermatopolymyositis
M13_DERMATOPOLY
dermatomyositis: Dermatomyositis (DM) is a type of idiopathic inflammatory myopathy characterized by evocative skin lesions and symmetrical proximal muscle weakness.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
571 |
4. Check minimum number of eventsNone |
571 |
5. Include endpoints |
613 |
6. Filter based on genotype QC (FinnGen only) |
549 |
Control definitions (FinnGen only)
- Control exclude
- M13_SYSTCONNECT
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M30-M36
- Name in latin
- Dermato[poly]myositis
Similar endpoints
↥List of similar endpoints to
Dermatopolymyositis
based on the number of shared cases.
Similar with more cases:
- Systemic connective tissue disorders
- Autoimmune diseases related-to ILD
- Autoimmune diseases
- Used for control exclusion in common control thyroid runs
- Diseases of the musculoskeletal system and connective tissue
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 549 | 342 | 207 |
| Unadjusted period prevalence (%) | 0.11 | 0.12 | 0.09 |
| Median age at first event (years) | 55.37 | 53.60 | 58.30 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 565
- Matched controls
- 5650
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M33.2
ICD-10 Finland
Polymyositis
+∞
312.5
270
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
19.5
288.4
305
320
L04AX01
ATC
azathioprine; systemic
31.3
240.3
169
76
M33.9
ICD-10 Finland
Dermatopolymyositis, unspecified
+∞
220.7
197
*
L04AX03
ATC
methotrexate; systemic
13.5
196.4
237
288
M33.1
ICD-10 Finland
Other dermatomyositis
+∞
194.3
175
*
P01BA02
ATC
hydroxychloroquine; oral
13.0
166.9
193
217
G72.9
ICD-10 Finland
Myopathy, unspecified
47.5
142.8
85
21
NJ3BG
NOMESCO Finland
MRI examination of extremities with high intensity magnet
86.3
141.2
75
10
L04AA06
ATC
mycophenolic acid; systemic
36.4
131.4
84
27
M60.9
ICD-10 Finland
Myositis, unspecified
200.0
124.0
125
8
H02AB06
ATC
prednisolone; systemic
8.1
103.0
457
1940
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
9.1
101.1
144
205
M05BA04
ATC
alendronic acid; oral
8.1
97.3
156
254
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
6.0
96.2
375
1394
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
8.6
80.6
116
165
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
447.2
80.0
78
*
NXL00
NOMESCO Finland
Biopsy of muscle
420.5
75.7
74
*
L01BA01
ATC
methotrexate; systemic
12.0
71.4
76
72
L04AD01
ATC
ciclosporin; systemic
20.1
67.2
53
29
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
6.1
67.0
138
284
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
8.1
62.0
91
131
H02AB07
ATC
prednisone; oral
5.1
60.5
161
413
M60.8
ICD-10 Finland
Other myositis
630.1
58.8
57
*
NJ3CG
NOMESCO Finland
Extensive MRI examination of extremities with median high magnet
88.6
57.3
63
8
L04AA01
ATC
[U] ciclosporin
23.2
52.9
39
18
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
64.8
46.2
53
9
J99.1*M33.2
ICD-10 Finland
Respiratory disorders in polymyositis
+∞
44.4
42
*
L88
ICPC
Rheumatoid/seropositive arthritis
7.3
41.7
65
99
M33.0
ICD-10 Finland
Juvenile dermatomyositis
+∞
40.1
38
*
M05BA07
ATC
risedronic acid; oral
8.2
39.7
55
73
L99
ICPC
Musculoskeletal disease other
10.5
38.8
44
45
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
5.1
37.8
87
193
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.1
37.6
358
2007
M35.3
ICD-10 Finland
Polymyalgia rheumatica
10.7
35.8
40
40
M35.1
ICD-10 Finland
Other overlap syndromes
+∞
34.7
33
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.0
34.2
233
1073
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
9.3
32.3
40
46
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
8.8
31.6
41
50
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
295.4
28.0
28
*
ZX120
NOMESCO Finland
Intravenous
3.7
26.9
95
290
J99.1*M33.9
ICD-10 Finland
Respiratory disorders in dermatopolymyositis
+∞
26.2
25
*
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
31.8
25.3
33
11
H02AB09
ATC
hydrocortisone; systemic
7.9
24.9
35
47
TGC00
NOMESCO Finland
Bronchial lavation
6.1
22.7
41
72
G72.8
ICD-10 Finland
Other specified myopathies
7.6
22.7
33
46
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.1
22.6
114
432
L19
ICPC
Muscle symptom/complaint NOS
6.1
22.3
40
70
7104A
ICD-9 Finland
Diffuse diseases of connective tissue, Polymyositis
+∞
22.0
21
*
71610
ICD-8 Finland
Polymyositis and dermatomyositis, Polymyositis
+∞
22.0
21
*
NGA20
NOMESCO Finland
Exploration of soft tissue knee or lower leg, open
52.2
21.3
25
5
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
5.6
20.9
41
78
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.4
20.9
194
998
R50.9
ICD-10 Finland
Fever, unspecified
2.8
20.6
122
503
XX9XE
NOMESCO Finland
Other ultrasound examination
23.4
20.6
29
13
XG410
NOMESCO Finland
Flow-volume spirometry
4.9
20.0
46
101
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.5
19.6
73
229
L28
ICPC
Limited function/disability (L)
2.6
19.6
148
689
XA402
NOMESCO Finland
ENMG
6.3
19.2
33
55
M33
ICD-10 Finland
Dermatopolymyositis
+∞
18.9
18
*
XPX04
NOMESCO Finland
Angioscopy
196.2
18.6
19
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
18.3
161
801
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.0
18.1
92
348
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
7.0
18.0
28
42
M05BX04
ATC
denosumab; parenteral
3.7
16.9
57
167
J99.1
ICD-10 Finland
Respiratory disorders in other diffuse connective tissue disorders
+∞
16.7
16
*
R13
ICD-10 Finland
Dysphagia
3.3
16.7
66
215
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.4
16.6
151
758
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
5.6
16.5
32
60
R4110
NOMESCO Finland
Physiotherapy
2.2
16.5
194
1084
C03CA01
ATC
furosemide; systemic
2.2
16.3
211
1223
C08CA05
ATC
nifedipine; systemic
3.7
16.2
55
162
JN4BD
NOMESCO Finland
Extensive body CT
2.9
16.2
82
309
R4120
NOMESCO Finland
Occupational therapy
3.4
16.0
62
199
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.4
15.8
133
644
NJ3DG
NOMESCO Finland
Very extensive MRI examination of extremities with high intensity magnet
+∞
15.7
15
*
M13.9
ICD-10 Finland
Arthritis, unspecified
3.3
15.5
61
198
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.7
15.4
50
143
A02BC02
ATC
pantoprazole; systemic
2.2
15.4
413
3121
M79.0
ICD-10 Finland
Rheumatism, unspecified
4.9
15.1
34
73
D07AC01
ATC
betamethasone; topical
2.1
15.0
234
1446
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.8
15.0
81
316
71600
ICD-8 Finland
Polymyositis and dermatomyositis, Dermatomyositis
+∞
14.6
14
*
E0000UV, ,
ATC
2.0
14.3
265
1734
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.3
13.8
56
185
N03AX16
ATC
[U] pregabalin
2.2
13.7
155
843
G72.4
ICD-10 Finland
Inflammatory myopathy, not elsewhere classified
+∞
13.6
13
*
7103B
ICD-9 Finland
Diffuse diseases of connective tissue, Dermatomyositis[DERMATOMYOSITIS ADULTORUM]
+∞
13.6
13
*
Z01.8
ICD-10 Finland
Other specified special examinations
2.2
13.6
152
824
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.9
13.5
66
243
Z3226
NOMESCO Finland
Physiotherapist
2.2
13.5
132
678
R06.0
ICD-10 Finland
Dyspnoea
2.0
13.0
182
1071
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.7
12.9
76
309
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.8
12.7
39
107
A02BC01
ATC
omeprazole; systemic
2.0
12.5
174
1020
N28
ICPC
Limited function/disability (N)
6.0
12.4
22
38
G71.9
ICD-10 Finland
Primary disorder of muscle, unspecified
38.5
12.3
15
*
L29
ICPC
Musculoskeletal sympt/complt other
2.7
12.2
70
281
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.2
12.0
49
162
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
3.2
12.0
48
157
1XC02, ,
NOMESCO Finland
19.4
11.6
17
9
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
4.5
11.1
27
62
R4190
NOMESCO Finland
Nutritional therapy
3.7
11.0
36
103
GD1AD
NOMESCO Finland
Thorax CT examination
2.9
11.0
53
193
A07AA02
ATC
nystatin; oral
3.0
10.9
51
183
D07AB08
ATC
desonide; topical
2.4
10.9
81
368
UJF32
NOMESCO Finland
Coloscopy
2.0
10.9
160
949
NG4AA
NOMESCO Finland
Lower leg X-ray examination
3.8
10.8
33
90
M62.9
ICD-10 Finland
Disorder of muscle, unspecified
22.0
10.7
15
7
J05AB01
ATC
aciclovir; systemic
2.0
10.6
144
829
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.7
10.6
59
233
A28
ICPC
Limited function/disability NOS
2.1
10.5
120
649
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.0
10.5
153
903
M60.0
ICD-10 Finland
Infective myositis
+∞
10.4
10
*
H26.3
ICD-10 Finland
Drug-induced cataract
12.4
10.4
18
15
M05BA06
ATC
ibandronic acid; systemic
5.3
10.4
21
41
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.3
10.3
81
376
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
10.3
109
572
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.0
10.2
47
167
XQ848
NOMESCO Finland
Dermatological photography
4.1
10.2
28
71
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
3.6
10.0
34
100
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
40.8
10.0
12
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.5
10.0
65
277
B07.9
ICD-10 Finland
Verruca simplex
3.8
9.9
31
86
E000001, ,
ATC
2.0
9.9
124
693
L04AA13
ATC
[U] leflunomide
4.7
9.9
23
51
M81.4
ICD-10 Finland
Drug-induced osteoporosis
20.5
9.8
14
7
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.5
9.6
33
98
M05BB03
ATC
alendronic acid and colecalciferol; oral
4.5
9.4
23
53
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
3.1
9.3
39
131
SPAT1231
SPAT
Assessment of adjustments needed in living environment
5.1
9.2
19
38
SPAT1229
SPAT
Assessment of need for aid
2.7
9.1
51
202
H05AA02
ATC
teriparatide; parenteral
15.9
9.1
14
9
318
Kela drug reimbursment
Teriparatide
15.9
9.1
14
9
TQW80
NOMESCO Finland
Local dermatologic skincare
4.4
8.9
22
51
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
12.8
8.9
15
12
M79.1
ICD-10 Finland
Myalgia
2.1
8.8
99
530
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.0
8.8
117
666
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
14.3
8.7
14
10
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.3
8.7
70
329
L93.0
ICD-10 Finland
Discoid lupus erythematosus
16.6
8.6
13
8
UJF30
NOMESCO Finland
Ileoscopy through colon
2.3
8.5
69
325
XQ841
NOMESCO Finland
Examination of dermatosis with microscope
91.4
8.4
9
*
Z50.1
ICD-10 Finland
Other physical therapy
2.8
8.4
43
162
J01DB01
ATC
cefalexin; oral
1.9
8.4
464
3973
QC6S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in hand
+∞
8.4
8
*
M34.1
ICD-10 Finland
CR(E)ST syndrome
+∞
8.4
8
*
G73.7*M35.0
ICD-10 Finland
Myopathy in sicca syndrome [Sjögren]
+∞
8.4
8
*
7103A
ICD-9 Finland
Diffuse diseases of connective tissue, Dermatomyositis[DERMATOMYOSITIS JUVENILIS]
+∞
8.4
8
*
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.4
8.3
30
92
5BA08, ,
NOMESCO Finland
14.7
8.2
13
9
R1250
NOMESCO Finland
Evaluation of functional capability
4.0
8.2
23
59
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.5
8.2
28
83
J01FF01
ATC
clindamycin; systemic
1.8
8.1
159
1020
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.1
8.1
82
422
A02BC05
ATC
esomeprazole; systemic
1.7
8.1
234
1673
N99
ICPC
Neurological disease other
7.4
8.0
18
25
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.3
8.0
62
286
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.7
7.9
168
1101
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
3.7
7.9
25
70
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.4
7.9
56
248
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.0
7.9
89
476
JDB10
NOMESCO Finland
Percutaneous gastrostomy
8.6
7.9
16
19
3015
Kela drug reimbursment
Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia
9.6
7.8
15
16
XG466
NOMESCO Finland
Sleep oxymetry
3.6
7.8
25
71
K90.0
ICD-10 Finland
Coeliac disease
3.6
7.8
25
71
H02AB04
ATC
methylprednisolone; systemic
2.0
7.7
89
480
D07AC13
ATC
mometasone; topical
1.7
7.7
170
1125
G71.08
ICD-10 Finland
Other muscular dystrophy
45.6
7.7
9
*
J01MA12
ATC
levofloxacin; systemic
1.9
7.7
108
623
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.7
7.7
192
1314
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
3.2
7.7
31
102
EBA10
NOMESCO Finland
Operative extraction of tooth
2.1
7.5
75
384
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.6
7.5
251
1853
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
4.5
7.5
18
41
C07AB07
ATC
bisoprolol; oral
1.6
7.5
280
2125
N02AX02
ATC
tramadol; systemic, rectal
1.6
7.5
246
1808
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
3.3
7.4
28
89
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.3
7.4
28
89
294
Kela drug reimbursment
Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia
11.1
7.3
13
12
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
+∞
7.3
7
*
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
+∞
7.3
7
*
M31.1
ICD-10 Finland
Thrombotic microangiopathy
+∞
7.3
7
*
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
+∞
7.3
7
*
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.4
7.3
51
225
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.4
7.3
50
219
S18
ICPC
Laceration/cut
1.6
7.2
269
2031
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
7.2
228
1654
Z3229
NOMESCO Finland
Other healthcare associate professional
2.3
7.2
55
252
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
3.3
7.2
27
85
B01AC24
ATC
ticagrelor; oral
3.3
7.2
27
85
WX892
NOMESCO Finland
Monitored bed care
2.4
7.2
50
220
D07AB02
ATC
hydrocortisone butyrate; topical
1.7
7.2
168
1128
QCA99
NOMESCO Finland
Other local destruction of skin of upper limb
30.4
7.2
9
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
7.1
93
524
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
3.2
7.1
27
86
SPAT1254
SPAT
Administration of medicine
2.0
7.0
83
451
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
3.5
7.0
24
71
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.7
7.0
38
148
ZXD05
NOMESCO Finland
Urgent procedure
1.7
7.0
166
1117
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.7
6.9
163
1094
A41.9
ICD-10 Finland
Sepsis, unspecified
3.3
6.9
26
82
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
14.0
6.9
11
8
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
4.2
6.9
18
44
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
8.4
6.9
14
17
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.0
6.8
30
104
S06
ICPC
Rash localized
2.6
6.8
38
150
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.1
6.8
66
334
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.3
6.8
25
78
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
16.9
6.8
10
6
N06AA09
ATC
amitriptyline; systemic
2.1
6.7
62
307
A02BC03
ATC
lansoprazole; oral
1.7
6.7
164
1110
Z3231
NOMESCO Finland
Registered nurse
1.7
6.7
155
1034
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
6.6
6.7
16
25
Z2221
NOMESCO Finland
Medical doctor
1.7
6.7
150
994
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.4
6.6
23
69
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
10.2
6.6
12
12
B02.9
ICD-10 Finland
Zoster without complication
2.4
6.5
47
210
RF420, ,
NOMESCO Finland
5.8
6.5
17
30
WZA10
NOMESCO Finland
Extensive medical or dental certificate
5.8
6.5
17
30
J05AB11
ATC
valaciclovir; oral
1.9
6.5
93
540
JN3AD
NOMESCO Finland
Abdominal CT examination
2.0
6.5
77
420
M60.1
ICD-10 Finland
Interstitial myositis
70.6
6.4
7
*
I50.9
ICD-10 Finland
Heart failure, unspecified
1.9
6.4
87
497
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
8.3
6.4
13
16
J01DA01
ATC
[U] cefalexin
1.6
6.4
340
2765
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.6
6.3
165
1133
TKC20
NOMESCO Finland
Catheterisation of bladder
2.4
6.3
43
187
M31.3
ICD-10 Finland
Wegener granulomatosis
+∞
6.3
6
*
6BA02, ,
NOMESCO Finland
27.0
6.2
8
*
A01AB09
ATC
miconazole; local oral
2.2
6.2
56
275
M79.7
ICD-10 Finland
Fibromyalgia
3.3
6.2
23
72
D07AD01
ATC
clobetasol; topical
1.8
6.2
94
555
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.5
6.2
39
164
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
7.8
6.1
13
17
SPAT1255
SPAT
Intravenous administration of medicine
2.5
6.1
38
159
D02AX
ATC
Other emollients and protectives
3.2
6.1
23
73
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
4.0
6.0
17
44
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
6.0
144
967
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
224
105
34.69
317.71
1.8
1.1
61.53
—
u/ml
—
14
0
145
26
74.68
264.38
1.4
1.0
—
—
—
0
0
188
158
17.33
197.39
6.2
2.0
704.29
296.18
ug/l
0.82
181
150
114
36
39.42
180.57
1.3
1.1
103.50
—
u/ml
—
8
0
166
181
12.57
145.41
2.3
1.3
6.44
4.25
iu/ml
0.74
49
38
75
16
53.90
130.01
1.3
1.0
—
—
—
0
0
424
1474
8.52
126.99
13.2
2.1
263.78
248.98
u/l
0.11
418
1406
124
128
12.13
111.41
1.6
1.1
12.03
3.47
u/ml
0.53
29
12
123
126
12.20
111.08
1.5
1.1
1.72
3.04
u/ml
—
16
7
136
173
10.04
104.67
1.5
1.1
4.06
2.67
u/ml
—
8
7
49
16
33.44
75.47
1.3
1.1
—
—
—
0
0
92
106
10.17
75.41
1.4
1.1
58.77
13.14
u/ml
—
27
8
54
38
15.61
60.38
1.4
1.1
—
—
—
0
0
49
32
16.67
56.92
1.4
1.1
—
—
—
0
0
51
36
15.47
56.87
1.4
1.1
—
—
—
0
0
49
34
15.69
55.11
1.4
1.1
—
—
—
0
0
49
34
15.69
55.11
1.4
1.1
—
—
—
0
0
48
33
15.80
54.24
1.4
1.1
—
—
—
0
0
89
150
6.86
52.26
1.6
1.5
254.06
0.16
iu/ml
0.47
13
22
149
483
3.83
39.59
2.1
2.1
350.35
392.25
nmol/l
0.71
142
451
444
2783
3.78
39.40
22.0
9.9
4.17
4.09
e9/l
0.37
427
2432
367
2252
2.80
29.75
11.6
6.5
1.21
1.21
mmol/l
0.22
353
2069
54
100
5.86
28.45
9.8
6.5
519.78
207.46
iu/ml
—
9
13
215
1029
2.76
28.31
2.1
1.5
2.31
2.48
g/l
0.55
167
611
389
2495
2.79
28.27
13.2
7.1
1.21
1.21
mmol/l
0.31
350
2149
352
2210
2.57
25.67
3.5
2.5
77.43
77.54
nmol/l
0.03
336
1985
66
173
4.19
23.01
3.0
2.9
—
—
—
0
0
384
2616
2.46
21.87
6.1
3.9
16.54
2.85
estimate
0.38
83
571
478
3619
3.08
21.86
14.3
4.0
14.64
11.83
mm/h
4.17
469
3360
53
124
4.61
21.34
3.7
2.7
0.00
0.00
g/l
-0.00
53
119
333
2148
2.34
21.25
8.0
4.9
34.12
35.72
g/l
4.68
324
2029
379
2588
2.41
21.13
6.1
3.8
0.00
0.00
estimate
-0.00
82
560
170
822
2.53
20.91
6.7
3.4
0.80
0.81
mmol/l
0.77
164
783
171
831
2.52
20.80
2.6
1.9
—
—
—
0
0
382
2639
2.38
20.40
6.2
3.9
0.00
0.57
estimate
0.51
82
535
32
49
6.86
20.22
2.3
1.5
—
—
—
0
0
25
30
8.67
19.39
2.2
2.0
185.40
231.22
e6/l
0.43
20
23
254
1511
2.24
19.06
4.8
3.2
1157.71
1261.21
ng/l
0.21
231
1287
55
145
4.09
18.97
1.8
1.5
—
—
—
0
0
55
145
4.09
18.97
5.2
4.8
33.19
45.21
mg/l
0.36
49
126
25
31
8.39
18.90
2.1
1.9
364.17
485.57
e6/l
0.61
18
23
56
151
4.01
18.73
1.7
1.5
—
—
—
0
0
293
1869
2.18
18.21
5.7
3.8
178.65
93.46
e6/l
0.40
215
1318
54
145
4.01
18.15
5.3
4.8
45.34
96.10
mg/l
0.63
49
124
129
595
2.51
17.18
2.5
1.9
—
—
—
0
0
90
347
2.90
17.06
4.6
3.4
169.71
182.78
ng/l
0.15
81
321
132
630
2.43
16.24
2.5
1.8
—
—
—
0
0
29
25
12.16
16.21
2.2
2.2
—
—
—
0
0
84
330
2.82
15.32
2.5
2.5
22.93
24.06
au/ml
—
8
22
257
1639
2.04
15.13
4.6
3.2
76.64
102.82
e6/l
0.16
210
1260
194
1118
2.12
15.00
3.5
2.5
3.36
6.04
e6/l
2.44
181
1025
50
146
3.66
14.90
1.3
1.2
—
—
—
0
0
45
123
3.89
14.74
1.8
1.4
—
—
—
0
0
209
1250
2.07
14.55
2.8
2.2
3.03
2.96
mg/l
0.16
189
1070
24
39
6.38
14.31
1.3
1.1
74.00
95.00
titre
—
10
6
37
90
4.33
14.15
1.4
1.4
—
—
—
0
0
227
1411
2.02
14.11
4.5
3.1
0.32
0.46
e6/l
0.76
182
1034
105
482
2.45
13.92
3.1
2.4
0.21
0.22
g/l
0.24
100
454
131
664
2.27
13.84
8.4
5.5
1.07
1.05
mmol/l
0.46
126
619
197
1175
2.04
13.65
1.4
1.3
0.98
1.59
u/ml
0.70
43
323
35
84
4.38
13.61
1.4
1.4
144.38
145.18
au/ml
—
10
32
31
68
4.77
13.45
1.1
1.2
6.20
4.78
u/ml
0.12
15
23
37
98
3.97
12.65
1.8
1.6
—
—
—
0
0
249
1649
1.91
12.47
6.6
3.3
49.36
32.09
u/l
3.21
236
1561
312
2232
1.89
12.22
25.1
11.3
0.00
0.00
e9/l
0.01
285
1836
35
92
3.99
12.09
1.2
1.4
290.45
255.72
u/ml
0.21
24
46
157
901
2.03
11.85
1.4
1.3
56.25
35.15
iu/ml
0.67
49
278
43
133
3.42
11.74
6.1
4.5
2.70
3.20
ratio
0.12
26
73
151
860
2.03
11.61
3.8
3.0
0.59
1.02
e6/l
2.80
98
450
36
100
3.78
11.52
2.0
1.4
—
—
—
0
0
81
359
2.47
11.49
2.0
1.6
—
—
—
0
0
349
2621
1.87
11.39
9.8
6.7
10.05
11.46
umol/l
3.31
338
2496
31
78
4.15
11.35
1.5
1.5
—
—
—
0
0
25
53
4.89
11.28
1.1
1.2
—
—
—
0
0
23
27
8.83
11.12
2.1
2.9
47.83
42.51
%
0.48
12
13
81
372
2.37
10.60
2.8
2.3
17.34
6.92
ug/l
2.45
71
328
28
70
4.16
10.34
1.1
1.2
4.36
4.27
u/ml
0.02
11
33
28
72
4.04
9.97
2.0
1.5
—
—
—
0
0
28
73
3.98
9.79
1.9
1.5
—
—
—
0
0
24
56
4.43
9.67
1.2
1.4
—
—
—
0
0
246
1721
1.76
9.60
3.8
3.5
2.33
2.36
mmol/l
2.66
235
1565
66
290
2.44
9.50
1.9
1.8
—
—
—
0
0
225
1540
1.77
9.43
2.9
2.5
54.06
63.62
u/l
1.33
210
1428
23
53
4.48
9.41
1.6
1.9
—
—
—
0
0
24
59
4.20
9.06
1.6
1.8
—
—
—
0
0
304
2294
1.70
8.76
17.0
13.5
1.28
1.23
inr
0.74
261
1894
106
584
2.00
8.72
14.1
7.4
5.21
5.12
kpa
0.35
96
566
106
584
2.00
8.72
14.0
7.4
10.98
12.31
kpa
1.91
96
568
133
792
1.89
8.71
1.8
1.7
1144.00
1183.69
nmol/l
0.20
110
600
303
2289
1.70
8.66
4.0
3.0
180.42
118.14
ug/l
2.27
292
2131
32
102
3.27
8.36
1.5
1.4
—
—
—
0
0
186
1244
1.74
8.23
4.2
2.8
359.14
339.35
umol/l
1.69
173
1096
103
573
1.98
8.22
14.4
7.6
1.83
0.89
mmol/l
1.00
83
483
138
846
1.84
8.20
1.3
1.3
32.67
14.02
u/ml
0.65
40
309
21
53
4.08
7.68
1.3
1.4
26.83
64.26
%
2.56
12
39
150
965
1.75
7.51
6.5
4.0
209.84
286.28
ng/l
0.37
129
747
389
3211
1.68
7.35
6.8
4.7
14.67
2340.85
e6/l
—
6
52
206
1453
1.66
7.31
6.8
3.9
0.00
0.00
estimate
0.50
80
524
33
118
2.91
7.13
1.2
1.7
—
—
—
0
0
17
40
4.35
6.79
1.1
1.0
—
—
—
0
0
204
1461
1.62
6.69
1.9
1.7
19.41
20.75
nmol/l
0.71
181
1229
198
1408
1.63
6.68
4.7
3.4
0.34
0.07
estimate
0.37
73
442
34
129
2.74
6.60
3.1
2.9
2.22
1.92
index
0.09
14
75
353
2884
1.60
6.57
9.7
5.0
6.69
6.70
mmol/l
0.06
343
2741
14
19
7.53
6.44
1.9
1.3
—
—
—
0
0
96
567
1.83
6.32
3.4
3.1
6.55
7.83
umol/l
0.52
85
503
12
13
9.40
6.31
1.9
1.3
8.55
8.13
ug/l
0.17
12
13
255
1948
1.56
6.25
6.1
3.8
1.37
0.04
estimate
0.48
73
466
34
135
2.62
6.06
1.4
1.3
—
—
—
0
0
123
792
1.71
6.01
4.3
3.1
3.26
2.25
e6/l
0.68
72
384
104
639
1.77
6.00
2.4
2.3
193.88
121.79
ug/g
0.84
90
506
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
33
130
2.63
5.98
4.6
2.6
0.35
0.38
iu/ml
0.21
20
67
29
107
2.80
5.95
2.3
1.4
—
—
—
0
0
13
19
6.97
5.76
1.9
3.9
1062.00
1009.21
u/ml
0.06
13
19
14
23
6.21
5.72
1.0
1.2
—
—
—
0
0
12
16
7.64
5.65
3.0
2.4
35.33
41.70
g/l
1.54
12
16
27
104
2.68
5.13
1.4
1.5
—
—
—
0
0
9
9
10.14
5.04
1.1
1.2
—
—
—
0
0
15
33
4.64
4.90
1.5
3.7
360.73
1014.21
mg
1.66
15
33
272
2191
1.47
4.75
2.4
2.1
95.19
96.12
pmol/l
0.11
153
1134
241
1902
1.47
4.65
5.9
3.8
91.38
36.22
ng/l
2.72
205
1353
56
308
1.91
4.59
4.4
4.0
1.90
1.89
mmol/l
0.01
50
231
167
1237
1.50
4.39
7.2
4.0
90.27
91.17
%
0.18
161
1211
140
1002
1.53
4.32
1.6
1.8
52632025.66
19976512.78
pmol/l
0.26
133
836
10
16
6.34
4.31
1.1
1.1
—
—
—
0
0
8
9
9.00
4.29
1.0
1.2
—
—
—
0
0
14
34
4.20
4.23
1.1
1.1
0.11
0.08
nmol/l
—
5
5
153
1121
1.50
4.22
2.2
1.8
1.30
1.24
mg/l
0.09
119
892
29
128
2.33
4.20
1.6
1.5
3712.57
16676.80
e6/l
1.60
21
90
12
26
4.69
4.07
1.0
1.0
—
—
—
0
0
76
476
1.69
4.07
2.4
2.4
316.31
34.12
u/l
0.51
65
398
7
7
10.10
4.02
3.1
1.4
—
—
—
0
0
31
144
2.22
4.00
1.4
1.1
—
—
—
0
0
16
53
3.08
3.99
1.5
1.6
—
—
—
0
0
16
53
3.08
3.99
1.5
1.6
—
—
—
0
0
16
53
3.08
3.99
1.5
1.6
—
—
—
0
0
23
94
2.51
3.93
1.5
1.2
—
—
—
0
0
23
94
2.51
3.93
1.5
1.2
—
—
—
0
0
6
5
12.11
3.77
1.0
1.0
—
—
—
0
0
30
143
2.16
3.66
1.3
1.1
—
—
—
0
0
48
274
1.82
3.55
22.8
9.0
16.05
15.76
%
0.32
42
264
137
1014
1.46
3.53
2.4
2.9
2.47
2.45
mmol/l
0.59
118
923
19
75
2.59
3.50
1.1
1.1
—
—
—
0
0
10
22
4.61
3.44
1.0
1.0
98.65
197.54
iu/ml
—
10
22
31
156
2.04
3.31
1.5
1.3
—
—
—
0
0
150
1143
1.43
3.29
7.2
4.0
1.02
1.02
kg/l
0.41
128
765
75
501
1.57
3.12
5.4
4.1
1.81
1.81
mmol/l
0.01
70
435
11
30
3.72
3.10
1.2
1.2
59.55
33.35
mg/l
0.81
11
24
502
4709
1.59
3.06
36.6
15.2
20.42
23.64
mg/l
1.88
467
3885
33
177
1.92
2.98
2.7
1.9
—
—
—
0
0
43
255
1.74
2.84
1.6
1.4
—
—
—
0
0
42
248
1.75
2.81
1.0
1.0
—
—
—
0
0
30
159
1.94
2.81
1.3
1.4
294.29
287.94
ug/g
0.05
21
95
47
289
1.68
2.73
3.1
3.2
4.25
4.48
pmol/l
1.24
41
254
61
402
1.58
2.70
6.0
3.8
1.21
1.23
mmol/l
1.48
56
348
10
29
3.49
2.70
1.0
1.0
—
—
—
0
0
9
24
3.79
2.68
1.0
1.0
1433.11
1249.71
miu/ml
—
9
24
9
24
3.79
2.68
3.3
1.8
61.56
74.73
ug/l
—
9
24
59
389
1.58
2.61
2.1
1.5
—
—
—
0
0
12
42
2.90
2.56
1.5
1.5
—
—
—
0
0
40
240
1.72
2.55
1.4
1.3
—
—
—
0
0
356
3187
1.32
2.54
4.5
3.3
55.42
47.82
u/l
0.83
346
2991
10
31
3.26
2.53
1.0
1.1
304.00
280.15
mg/l
—
10
26
14
57
2.49
2.46
1.2
1.2
—
—
—
0
0
6
12
5.04
2.40
1.2
1.3
—
—
—
0
0
10
34
2.98
2.29
1.4
1.1
—
—
—
0
0
23
120
1.96
2.29
1.3
1.8
4.41
4.64
iu/l
—
8
46
7
18
3.92
2.26
1.9
1.3
—
—
—
0
0
28
472
0.57
2.23
2.2
2.0
3.70
3.44
ratio
0.36
21
382
13
54
2.44
2.21
1.4
1.3
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
7
19
3.72
2.15
1.6
1.8
156.90
134.32
%
—
7
19
6
14
4.32
2.15
1.8
1.3
—
—
—
0
0
27
154
1.79
2.08
1.4
1.4
—
—
—
0
0
5
10
5.03
2.07
1.2
1.8
0.58
0.47
e9/l
—
5
10
8
26
3.11
2.02
1.0
1.2
—
—
—
0
0
8
26
3.11
2.02
1.3
1.4
—
—
—
0
0
8
26
3.11
2.02
1.3
1.4
—
—
—
0
0
13
57
2.31
1.99
3.4
1.7
90.52
89.75
%
0.27
13
57
416
4430
0.77
1.98
4.9
4.3
1.49
1.27
mmol/l
3.79
397
4074
7
21
3.36
1.97
1.1
1.0
—
—
—
0
0
7
21
3.36
1.97
1.7
1.8
—
—
—
0
0
7
21
3.36
1.97
1.7
1.8
—
—
—
0
0
7
21
3.36
1.97
1.7
1.8
—
—
—
0
0
28
165
1.73
1.95
2.5
1.8
—
—
—
0
0
5
11
4.58
1.94
1.0
1.0
—
—
—
0
0
6
16
3.78
1.94
1.2
1.4
—
—
—
0
0
405
3751
1.28
1.91
5.3
4.4
14.99
14.81
pmol/l
0.74
386
3430
440
4640
0.77
1.83
5.6
5.1
1.41
1.48
mmol/l
2.84
420
4298
5
12
4.19
1.82
1.0
1.2
—
—
—
0
0
17
87
1.98
1.81
1.4
1.4
—
—
—
0
0
8
29
2.78
1.79
1.6
1.6
—
—
—
0
0
8
29
2.78
1.79
1.6
1.6
—
—
—
0
0
8
29
2.78
1.79
1.6
1.6
—
—
—
0
0
8
29
2.78
1.79
1.6
1.6
—
—
—
0
0
11
47
2.37
1.78
1.9
1.1
2.04
1.44
nmol/l
1.39
11
41
25
148
1.72
1.73
1.3
1.5
—
—
—
0
0
13
61
2.16
1.72
1.5
1.6
—
—
—
0
0
13
61
2.16
1.72
1.5
1.6
—
—
—
0
0
13
61
2.16
1.72
1.5
1.6
—
—
—
0
0
14
68
2.09
1.71
1.2
1.1
—
—
—
0
0
23
135
1.73
1.65
2.1
1.5
—
—
—
0
0
444
4662
0.78
1.63
5.6
5.2
4.75
4.64
mmol/l
1.44
424
4332
6
20
3.02
1.58
1.0
1.5
—
—
—
0
0
12
57
2.13
1.56
1.6
1.7
—
—
—
0
0
12
57
2.13
1.56
1.6
1.7
—
—
—
0
0
5
15
3.35
1.52
1.2
1.1
—
—
—
0
0
5
15
3.35
1.52
1.2
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
27
2.61
1.52
1.1
1.2
—
—
—
0
0
6
21
2.88
1.51
2.5
1.6
—
—
—
0
0
6
21
2.88
1.51
2.5
1.6
—
—
—
0
0
12
58
2.09
1.50
1.6
1.7
—
—
—
0
0
107
873
1.28
1.46
1.5
1.5
—
—
—
0
0
453
4730
0.79
1.44
6.1
6.0
2.83
2.71
mmol/l
2.20
435
4386
5
16
3.14
1.44
1.0
1.3
—
—
—
0
0
5
16
3.14
1.44
1.0
1.2
—
—
—
0
0
5
16
3.14
1.44
1.0
1.1
—
—
—
0
0
6
22
2.75
1.44
1.0
1.3
—
—
—
0
0
9
39
2.33
1.43
3.6
3.1
—
—
—
0
0
7
29
2.43
1.39
2.0
1.4
—
—
—
0
0
10
48
2.10
1.28
1.2
1.0
—
—
—
0
0
23
348
0.65
1.25
1.7
1.8
3.96
3.46
mmol/l
1.32
15
260
5
19
2.65
1.22
1.0
1.1
—
—
—
0
0
6
26
2.32
1.19
2.3
1.5
116.17
103.15
ng/l
—
6
26
67
530
1.30
1.17
2.8
4.4
2.76
34.14
ug/l
1.30
52
435
11
58
1.91
1.12
1.4
1.2
—
—
—
0
0
7
30
2.35
1.12
2.0
1.4
—
—
—
0
0
252
2300
1.17
1.10
3.6
2.7
—
—
estimate
—
0
0
137
1192
1.20
1.04
2.8
2.3
—
—
—
0
0
194
1745
1.17
1.00
3.4
3.4
6.59
7.46
mmol/l
2.30
171
1469
7
36
1.96
0.97
2.0
1.4
—
—
—
0
0
7
37
1.90
0.94
1.1
1.4
—
24.00
—
0
5
6
27
2.23
0.93
2.5
1.6
—
—
—
0
0
6
27
2.23
0.93
2.5
1.6
—
—
—
0
0
10
55
1.83
0.92
3.9
3.4
—
—
—
0
0
24
169
1.44
0.89
1.5
1.5
—
—
—
0
0
8
42
1.92
0.89
3.0
3.6
679.55
6.23
nmol/l
—
8
42
11
64
1.73
0.86
1.0
1.2
0.17
0.19
nmol/l
—
6
46
61
500
1.25
0.84
5.5
3.3
—
—
—
0
0
10
57
1.77
0.84
1.2
1.1
—
—
—
0
0
8
46
1.75
0.83
1.6
1.5
329.88
266.51
mu/l
—
8
39
8
46
1.75
0.83
1.4
1.1
74.75
102.83
pmol/l
—
8
46
28
208
1.36
0.79
2.9
3.4
19.82
1955.70
u/ml
1.42
22
179
443
4566
0.86
0.73
5.7
5.2
5.74
5.97
mmol/l
4.10
416
4191
9
144
0.62
0.70
1.7
2.0
36.67
40.81
nmol/l
—
9
139
21
152
1.40
0.70
1.2
1.3
319.81
264.51
miu/ml
—
5
68
456
4424
1.16
0.69
6.6
5.4
1.90
1.92
mu/l
0.13
439
4081
48
397
1.23
0.64
2.6
2.7
70.75
67.68
ml/min/173m2
0.13
16
173
66
565
1.19
0.63
1.4
1.8
1.48
1.46
%
0.10
50
495
38
466
0.80
0.63
2.7
2.0
—
—
—
0
0
5
30
1.67
0.61
3.0
3.9
1.00
1.13
%
—
5
30
181
1678
1.12
0.57
4.0
4.1
8.31
8.14
mg/mmol
0.02
115
1036
6
36
1.67
0.57
1.3
1.2
—
—
—
0
0
17
124
1.38
0.56
1.1
1.3
—
—
—
0
0
6
39
1.54
0.53
2.0
2.4
670.17
546.83
ml
—
6
23
17
127
1.35
0.50
3.7
2.1
121.56
131.01
g/l
—
9
103
7
46
1.53
0.48
1.9
2.3
13.71
13.17
%
—
7
46
507
4996
1.14
0.41
42.1
20.5
74.93
75.89
umol/l
0.15
502
4934
0
16
0.00
0.41
0.0
1.3
—
1.24
—
0
11
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
85
775
1.11
0.38
1.6
1.5
—
—
—
0
0
8
112
0.71
0.37
2.3
1.9
205.50
220.45
pmol/l
—
8
106
20
164
1.23
0.33
1.8
1.7
—
—
—
0
0
10
132
0.75
0.32
1.4
1.2
—
—
—
0
0
11
143
0.76
0.32
1.9
3.1
1.44
1.63
mmol/l
0.66
11
138
489
4824
1.10
0.31
35.0
18.5
139.37
139.72
mmol/l
2.21
479
4730
45
503
0.89
0.30
2.5
2.1
—
—
—
0
0
139
1314
1.08
0.30
5.0
5.5
3.67
2.34
ug/l
0.69
125
1188
11
141
0.78
0.29
1.2
1.2
1.56
1.54
g/l
0.04
11
141
461
4544
1.08
0.27
29.4
15.4
85.32
80.77
ml/min/173m2
3.84
444
4213
8
67
1.20
0.26
1.3
1.0
—
—
—
0
0
489
4832
1.09
0.26
35.5
18.6
3.95
3.97
mmol/l
1.28
479
4724
38
339
1.13
0.26
1.2
1.2
78.47
121.28
u/ml
—
10
130
10
78
1.29
0.24
1.2
1.5
—
—
—
0
0
507
5116
0.91
0.24
50.7
23.9
4.37
4.48
e12/l
5.34
500
5006
507
5113
0.92
0.22
50.8
23.9
260.97
249.90
e9/l
2.21
501
5019
5
42
1.19
0.21
1.2
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
0.06
—
0
6
0
10
0.00
0.21
0.0
1.0
—
0.14
—
0
5
0
10
0.00
0.21
0.0
1.0
—
3.12
—
0
5
12
99
1.22
0.19
1.9
1.3
0.95
0.91
nmol/l
—
7
81
294
2877
1.05
0.19
3.4
3.0
—
—
—
0
0
501
4970
1.07
0.17
29.5
12.0
31.26
25.64
u/l
5.62
495
4823
24
216
1.12
0.15
1.4
1.4
0.14
0.29
mg/l
—
5
90
65
618
1.06
0.13
5.5
5.0
30.45
31.79
%
0.59
49
400
13
148
0.88
0.12
1.7
1.2
0.97
0.90
g/l
0.35
13
148
102
1053
0.96
0.11
3.7
4.6
22.18
21.78
%
0.10
51
506
11
97
1.14
0.09
5.6
2.5
8.09
7.79
pmol/l
0.04
11
97
8
76
1.05
0.07
1.3
1.8
—
—
—
0
0
446
4477
0.98
0.04
7.2
6.5
39.61
39.34
mmol/mol
0.30
426
4194
14
149
0.94
0.03
1.8
1.4
—
—
—
0
0
27
263
1.03
0.01
2.3
2.1
—
—
—
0
0
14
134
1.05
0.00
1.6
2.4
13609.18
5525.73
u/l
—
6
47
21
213
0.99
0.00
2.4
2.1
—
—
—
0
0
55
554
0.99
0.00
9.2
6.3
—
—
—
0
0
79
792
1.00
0.00
2.8
3.2
0.93
0.76
ug/l
0.35
53
508
209
2087
1.00
0.00
2.0
2.0
1.54
1.33
mmol/l
1.99
177
1752
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
0.02
—
0
6
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
13.62
—
0
6
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.6
—
67.04
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
5
56
0.89
-0.00
1.2
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
8.0
—
6.04
—
0
5
6
62
0.97
-0.00
1.3
1.4
28.75
27.69
u/l
—
6
53
7
73
0.96
-0.00
2.1
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: M13_DERMATOPOLY – Dermatopolymyositis
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).